Pfizer Sales Force Stays: Changes Include “Modest” Cuts, No Lay-Offs
Executive Summary
Pfizer is not planning dramatic cuts in its sales force over the next three years - and the withdrawal of the COX-2 inhibitor Bextra is not likely to affect that plan
You may also be interested in...
Merck Commercial Pilot Set To Fly Nationwide
Merck is rolling out a new commercial model, including a realigned sales organization, nationwide following a successful pilot program, Global Human Health President Kenneth Frazier said
Merck Commercial Pilot Set To Fly Nationwide
Merck is rolling out a new commercial model, including a realigned sales organization, nationwide following a successful pilot program, Global Human Health President Kenneth Frazier said
Quality Not Quantity: Pfizer Cuts Sales Team To Increase Meaningful Contacts
Pfizer's decision to reduce its sales force reflects a change in the company's marketing strategy, but does not mean the firm is facing a shortage of products to support, according to CEO Jeffrey Kindler